Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage sensor responsible for excitation-contraction (EC) coupling in skeletal muscle is a specialized molecular module within the CaV1.1 L-type calcium channel (also known as the dihydropyridine receptor, DHPR). This sensor detects changes in membrane potential and transduces this electrical signal into mechanical activation of ryanodine receptor 1 (RyR1) channels on the sarcoplasmic reticulum, leading to rapid calcium release and muscle contraction. The voltage-sensing domains (VSDs) within CaV1.1, particularly VSD-I, undergo conformational rearrangements upon membrane depolarization, triggering RyR1 opening. Divalent cations, especially Ca2+, are essential for the sensor's function by binding at a "priming" site.
Voltage-dependent modulation of calcium channel activity; direct interaction with ryanodine receptor (RyR1)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage sensor for excitation-contraction coupling.